Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases that is headquartered in Philadelphia, Pennsylvania. It was founded in 2015 by Carl June, Bruce Levine, Yangbing Zhao, Anne Chew, James Riley, and Bruce Blazar.
The company conducts research and development around the aforementioned field of study. It uses laboratory and production facilities at the University of Pennsylvania, as well as its own production facility located near the city. It has multiple novel therapies, many of which are in the pre-clinical and clinical stages of development.
April 27, 2018
Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer
Tmunity Therapeutics, Inc. to Advance IND-Enabling Activities for Personalized Next-Generation Engineered T Cell Therapies with $10 Million Financing